"InDACtion" vs "3+7" Induction in AML

Clinical trial NCT02172872 · UNKNOWN

Trial details

NCT number: NCT02172872
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)

Start date: 2014-11-28
Primary completion: 2022-03-07
Enrollment: 606

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.